Delivery Order SPE2DB20D3103-SPE2DB25FP5S1
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,905.78, is for the delivery of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. It is not associated with a set-aside requirement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
- This is a $12,418.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565664131 - Ferumoxytol 510 mg/17 ml vial with a completion date of September 4, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and is responsible for providing this critical medical product to support federal healthcare programs and military treatment...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,126.04, is for the supply of Ferumoxytol 510 mg/17 ml vials to support federal healthcare programs. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a $2,170.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a medication used to treat iron deficiency anemia. The contract is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical. This...
- This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vial, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,108.26 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 17 mL vials of the injectable iron replacement medication ferumoxytol. The $13,498 firm fixed price contract has a period of performance through September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is a significant supplier of medical commodities to the U.S. federal government, including military treatment facilities and other healthcare providers. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Feraheme (ferumoxytol) 510 mg/17 mL vials. The $14,668.64 firm fixed-price contract has a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these injectable iron replacement therapy products to support military healthcare providers and programs. This contract is a task order under a larger DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,883.97 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 510 mg/17 ml vials of Ferumoxytol. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by November 30, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5S1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This specific delivery order for Ferumoxytol—an iron oxide nanoparticle used for iron replacement therapy—supports the Defense Health Agency and other government healthcare systems through the established pharmaceutical prime vendor relationship with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 7/18/25 |